These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2791710)

  • 1. Pharmacokinetics of miocamycin in patients with liver cirrhosis.
    Miglioli PA; Pivetta P; Orlando R; Palatini P; Varotto A; Okolicsanyi L
    Chemotherapy; 1989; 35(5):330-2. PubMed ID: 2791710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of miocamycin following intravenous administration to cattle.
    Litterio NJ; Rubio MR; Formentini EA; Díaz DC; Picco EJ; Encinas T; Boggio JC
    J Vet Med A Physiol Pathol Clin Med; 2000 Feb; 47(1):37-41. PubMed ID: 10841461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of ponsinomycine with repeated ingestion in healthy volunteers].
    Couet W; Reigner BG; Ingrand I; Girault J; Istin B; Bizouard J; Fourtillan JB
    Therapie; 1990; 45(2):105-9. PubMed ID: 2353325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of rokitamycin after single administration to healthy volunteers.
    Broggini M; Bottà V; Benvenuti C; Fonio W; Congedo M; Parini J
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):137-40. PubMed ID: 1936073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic data and therapeutic efficacy of miocamycin: serum, urinary and prostatic levels. Therapeutic aspects in acute urethral syndrome and non-gonococcal urethritis.
    Furneri PM; Roccasalva L; Fallica L; Tempera G
    J Chemother; 1989 Jul; 1(4 Suppl):581-2. PubMed ID: 16312542
    [No Abstract]   [Full Text] [Related]  

  • 6. Some features of miocamycin in the gynecological field: pharmacokinetic data using preoperative administration and therapeutic aspects against chlamydial infections.
    Furneri PM; Blandino G; Roccasalva L; Cianci A; Palumbo G; Tempera G
    J Chemother; 1989 Jul; 1(4 Suppl):585-6. PubMed ID: 16312544
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of miocamycin on theophylline kinetics in children.
    Principi N; Onorato J; Giuliani MG; Vigano A
    Eur J Clin Pharmacol; 1987; 31(6):701-4. PubMed ID: 3493905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis.
    Orlando R; Sawadogo A; Miglioli PA; Cappellazzo MG; Palatini P
    Chemotherapy; 1992; 38(1):1-6. PubMed ID: 1617997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miocamycin distribution in tonsillar and pulmonary tissues after repeated administration.
    Scaglione F; Falchi M; Nebuloni R; Cattaneo G; Pintucci JP; Mezzetti M; Zampella K; Saudelli M; Casini A; Fraschini F
    J Chemother; 1990 Dec; 2(6):384-9. PubMed ID: 2093111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis.
    Okolicsanyi L; Venuti M; Strazzabosco M; Orlando R; Nassuato G; Iemmolo RM; Lirussi F; Muraca M; Pastorino AM; Castelli G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):329-32. PubMed ID: 6086536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic profile of miocamycin in middle ear fluid and mucosa.
    Fraschini F; Scaglione F; Falchi M; Nebuloni R; Zampella K; Saudelli M; De Luca M; Casini A; Pintucci GP
    Acta Otolaryngol; 1991; 111(4):756-61. PubMed ID: 1950539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses.
    Okolicsanyi L; Venuti M; Strazzabosco M; Biral A; Orlando R; Iemmolo RM; Nassuato G; Muraca M; Padrini G; Miglioli PA
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):434-8. PubMed ID: 4044077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L; Venuti M; Strazzabosco M; Iemmolo RM; Nassuato G; Orlando R; Lirussi F
    Acta Physiol Hung; 1984; 64(3-4):393-400. PubMed ID: 6099684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and tolerability of telenzepine in patients with compensated liver cirrhosis].
    Reinicke A; Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1990 Nov; 40(11):1239-41. PubMed ID: 2085337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M; Suzuki H; Komiya I
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some pharmacokinetic data on miocamycin II. Concentrations in gynaecological tissues.
    Furneri PM; Cianci A; Garozzo A; Roccasalva L; Pinizzotto MR; Palumbo G; Tempera G
    Drugs Exp Clin Res; 1991; 17(3):181-5. PubMed ID: 1914845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-1. Toxicity of metabolites of miocamycin: acute toxicity of Mb1 in mice.
    Yokota M; Takeda U; Odaki M; Sasaki H; Kawaoto H; Itoh T; Koeda T
    Jpn J Antibiot; 1984 Aug; 37(8):1488-90. PubMed ID: 6334171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic study on midazolam in compensated liver cirrhosis.
    Rinetti M; Ascalone V; Colombi Zinelli L; Cisternino M
    Int J Clin Pharmacol Res; 1985; 5(6):405-11. PubMed ID: 2936689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-9. Toxicity of metabolites of miocamycin: subacute toxicity of Mb6 in rats.
    Yokota M; Takeda U; Odaki M; Sasaki H; Niizato T; Kawaoto H; Watanabe H; Ishiwatari N; Hayasaka H; Koeda T
    Jpn J Antibiot; 1984 Aug; 37(8):1532-45. PubMed ID: 6334179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.